TherapeuticsMD
TXMD
115 hedge funds and large institutions have $859M invested in TherapeuticsMD in 2015 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 24 reducing their positions, and 13 closing their positions.
653% more call options, than puts
Call options by funds: $11.1M | Put options by funds: $1.48M
162% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 13
96% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 24
26% more capital invested
Capital invested by funds: $680M → $859M (+$178M)
22% more funds holding
Funds holding: 94 → 115 (+21)
0.04% less ownership
Funds ownership: 1.31% → 1.27% (-0.04%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$5.01M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.79M |
| 3 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
+$3M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.29M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$13.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.4M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.4M |
| 4 |
VM
VHCP Management
New York
|
-$5.12M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.43M |
TXMD Hedge Fund Activity: Q2 2015 in Review
115 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q2 2015, worth a combined $859M — up 26% from $680M a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new TXMD positions and 13 closed out — a net gain of 21 holders — while 47 added to existing stakes and 24 trimmed.
The largest buyer was State Street, adding an estimated $5.01M. The largest seller was Deerfield Management, exiting entirely with an estimated $13.5M sold.
- 115 institutional investors held TherapeuticsMD (TXMD) as of Q2 2015, up from 94 in Q1 2015.
- Funds reported $859M of TherapeuticsMD stock for Q2 2015, up 26% quarter-over-quarter.
- 34 funds opened new TherapeuticsMD positions in Q2 2015 and 13 closed out, a net change of +21 holders.
- The largest TherapeuticsMD buyer in Q2 2015 was State Street, an estimated $5.01M added.
- The largest TherapeuticsMD seller in Q2 2015 was Deerfield Management, an estimated $13.5M sold.
Based on aggregated 13F filings for Q2 2015.